Gene · 3663
Papers4,211
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,211
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Variants in IRF5 Increase the Risk of Primary Sjögren's Syndrome in the Mexican Population. | Int J Mol Sci | 2026 | 41596252 | PubTator, text mining | PubMed |
| Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK Biobank. | Nat Commun | 2026 | 41593088 | PubTator, text mining | PubMed |
| MTHFR‑folate axis as a modulator of the epigenetic landscape in autoimmune diseases (Review). | Int J Mol Med | 2026 | 41574701 | PubTator, text mining | PubMed |
| Histone and non-histone (de)acetylation impact on the blood-brain barrier. | Fluids Barriers CNS | 2026 | 41566325 | PubTator, text mining | PubMed |
| Sensitive detection of plasma interferon regulatory factor-5 (IRF5) by solid-phase proximity ligation assay validates IRF5 high and low subgroups in patients with systemic lupus erythematosus. | Scand J Rheumatol | 2026 | 41367245 | PubTator, text mining | PubMed |
| Interferon regulatory factor 4-releasing 3D-printed scaffolds enhance spinal cord repair by modulating macrophage polarization. | Neural Regen Res | 2026 | 41017676 | PubTator, text mining | PubMed |
| Multimerin-1 modulates macrophage M2 polarization and enhances tumor cell stemness in glioblastoma. | Neurol Res | 2026 | 40544321 | PubTator, text mining | PubMed |
| Towards precision medicine for systemic lupus erythematosus and neuropsychiatric manifestations. | Expert Rev Precis Med Drug Dev | 2025 | 42281945 | PubTator, text mining | PubMed |
| Search for Potential VDR/Partner Composite Elements in Regulatory DNA of Genes Associated with Respiratory Infections and Atopic Diseases. | Int J Mol Sci | 2025 | 41516283 | PubTator, text mining | PubMed |
| Extracellular vesicles for macrophage reprogramming: an emerging paradigm in immunomodulatory therapeutics. | J Biol Eng | 2025 | 41430279 | PubTator, text mining | PubMed |
| Reduced Methylation of IRF5 Gene as a Biomarker for Gestational Diabetes Mellitus. | Med Sci Monit | 2025 | 41403108 | PubTator, text mining | PubMed |
| TRIM21 regulation of IRF-mediated type I interferon signaling in systemic autoimmune diseases. | Front Immunol | 2025 | 41383611 | PubTator, text mining | PubMed |
| Convergence of mRNA technology and chimeric antigen receptor therapy: targeted technology optimizing targeted therapy. | J Transl Med | 2025 | 41366793 | PubTator, text mining | PubMed |
| MicroRNA-mediated regulation of natural killer cells development, effector functions, and antitumor responses. | Cancer Cell Int | 2025 | 41331607 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals dynamic reprogramming of testicular immunity in Brucella-infected goat testis. | Zool Res | 2025 | 41320872 | PubTator, text mining | PubMed |
| Super-Enhancer-Associated circRHOQ Regulates Intramuscular Fat Deposition by Modulating the miR-5093/IRF5 Axis. | J Agric Food Chem | 2025 | 41252683 | PubTator, text mining | PubMed |
| Exploring the role of genetic variants in susceptibility to autoimmune Diseases: A molecular genetics approach. | Hum Immunol | 2025 | 41237580 | PubTator, text mining | PubMed |
| Monocyte-driven IFN and TNF programs orchestrate inflammatory networks in antisynthetase syndrome-associated interstitial lung disease. | Front Immunol | 2025 | 41209011 | PubTator, text mining | PubMed |
| B cell subpopulations and their role in the pathogenesis of primary Sjögren's syndrome: insights from single-cell RNA sequencing. | Front Immunol | 2025 | 41181153 | PubTator, text mining | PubMed |
| Isoliquiritigenin Inhibits Triple-Negative Breast Cancer Progression via Targeting the IRF5/SLC7A5/IDO1-Mediated Tryptophan Metabolism Pathway. | Oncol Res | 2025 | 41179282 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3663/papers?page=4